Skip to main content
Ono Pharmaceutical Co., Ltd. (TYO: 4528)
Japan flag Japan · Delayed Price · Currency is JPY
1,634.50
+3.00 (0.18%)
Dec 30, 2024, 9:00 AM JST

Ono Pharmaceutical Revenue

Ono Pharmaceutical had revenue of 122.66B JPY in the quarter ending September 30, 2024, a decrease of -11.56%. This brings the company's revenue in the last twelve months to 484.30B, down -1.00% year-over-year. In the fiscal year ending March 31, 2024, Ono Pharmaceutical had annual revenue of 502.67B with 12.41% growth.

Revenue (ttm)
484.30B
Revenue Growth
-1.00%
P/S Ratio
1.59
Revenue / Employee
125.69M
Employees
3,853
Market Cap
767.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024502.67B55.49B12.41%
Mar 31, 2023447.19B85.83B23.75%
Mar 31, 2022361.36B52.08B16.84%
Mar 31, 2021309.28B16.86B5.77%
Mar 31, 2020292.42B3.79B1.31%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Chugai Pharmaceutical 1,142.35B
Daiichi Sankyo Company 1,758.07B
HOYA Corporation 812.74B
Takeda Pharmaceutical Company 4,546.08B
Otsuka Holdings 2,269.56B
Terumo 986.67B
Astellas Pharma 1,772.16B
Olympus 973.60B
Revenue Rankings

Ono Pharmaceutical News

More News